Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell Neurocrine Biosciences Inc (NBIX) – Neurocrine Biosciences Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Neurocrine Biosciences (NBIX) trades at $158.52, up 1.72% on the day, with strong bullish signals from moving averages and a consensus price target of $192.77. The company reported robust Q1 2026 earnings of $1.94 per share, beating estimates, and completed the acquisition of Soleno Therapeutics, expanding its rare disease portfolio. Revenue grew 44% year-over-year to $811M, with a net income margin of 21.55% and ROE of 22.5%, demonstrating solid fundamental strength.
The outlook is positive, driven by continued growth in core products Ingrezza and Crenessity, plus potential from the Soleno acquisition. Key risks include integration challenges from the acquisition and pipeline execution. Wall Street sentiment is overwhelmingly bullish, with 32 Buy ratings and no Sells, though the stock trades at a premium valuation with a P/E of 24.07.
Read full analysis

Key Stats

  • Market Cap
    $15.73B
  • Sector
    Health
  • 3M Drawdown
    -5.34%
  • Enterprise Value
    $14.82B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    8 days
$158.66
52W Low: $123.02
30 May 2025
52W High: $161.32
13 May 2026

Neurocrine Biosciences Inc (NBIX) is currently valued at a market capitalization of $15.73B, with an enterprise value of $14.82B. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.02 and a high of $161.32, highlighting its annual price range. Over the past three months, Neurocrine Biosciences Inc has recorded a drawdown of -5.34%, reflecting recent price volatility. On average, investors hold Neurocrine Biosciences Inc for approximately 8 days, indicating typical investor behavior on the platform.

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.



People also bought


Global US Market Prices


Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.

Key Stats

  • Market Cap
    $15.73B
  • Sector
    Health
  • 3M Drawdown
    -5.34%
  • Enterprise Value
    $14.82B
  • Dividend Yield
    -
  • Trading Activity
    0% Buy | 100% Sell
  • Typical Hold Time
    8 days
$158.66
52W Low: $123.02
30 May 2025
52W High: $161.32
13 May 2026

Neurocrine Biosciences Inc (NBIX) is currently valued at a market capitalization of $15.73B, with an enterprise value of $14.82B. Over the past 52 weeks, Neurocrine Biosciences Inc has traded between a low of $123.02 and a high of $161.32, highlighting its annual price range. Over the past three months, Neurocrine Biosciences Inc has recorded a drawdown of -5.34%, reflecting recent price volatility. On average, investors hold Neurocrine Biosciences Inc for approximately 8 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!